Skip to content

Clinical trials

Phase 2 Dermatitis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis Phase: Phase 2 Country / region: United States Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20092
20121
20161
20182
20191
20204
20212
20223
20233
20243
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated7
Active, not recruiting4
Recruiting4
Withdrawn2
Enrolling by invitation1
Unknown status1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Aclaris Therapeutics, Inc.2
Apollo Therapeutics Ltd2
Forte Biosciences, Inc.2
GlaxoSmithKline2
Inmagene LLC2
University of Minnesota2
AbbVie1
Allakos Inc.1
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis30
Dermatitis, Atopic21
Eczema20
Skin Diseases13
Immune System Diseases7
Pruritus4
Skin Diseases, Eczematous4
Hidradenitis Suppurativa2
Skin Diseases, Genetic2
Acne Vulgaris1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.